Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis
- PMID: 17981921
- DOI: 10.1373/clinchem.2007.093492
Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis
Abstract
Background: The mechanism by which hypertriglyceridemia (HTG) leads to pancreatitis is not clear. We sought to determine whether the genes involved in pancreatic ductal or acinar cell injury, including the cationic trypsinogen gene [protease, serine, 1 (trypsin 1) (PRSS1)], the pancreatic secretory trypsin inhibitor gene [serine peptidase inhibitor, Kazal type 1 (SPINK1)], the cystic fibrosis transmembrane conductance regulator gene [cystic fibrosis transmembrane conductance regulator (ATP-binding cassette subfamily C, member 7) (CFTR)], and inflammation genes such as tumor necrosis factor [tumor necrosis factor, TNF superfamily, member 2 (TNF)] are associated with hyperlipidemic pancreatitis (HLP) in patients with HTG.
Methods: We performed genetic analysis of 126 HTG patients in Taiwan (46 with HLP and 80 without HLP). The entire coding and intronic regions of the PRSS1, SPINK1, and CFTR genes were identified by heteroduplex analysis techniques and were confirmed by sequencing analysis. The presence of 125G/C, 1001 + 11C>T, 1540A>G (Met470Val), 2694T>G, and 4521G>A in CFTR, the presence of 272C>T in SPINK1, and TNF promoter polymorphisms (nucleotide positions 1031, 863, 857, 308, and 308) were measured by direct sequencing.
Results: Of the 126 HTG patients, 13 (10.3%) carried a CFTR mutation. No PRSS1 or SPINK1 mutations were detected in our patients or in HTG controls. The CFTR gene mutation rates in HTG with and without HLP were 26.1% (12 of 46) and 1.3% (1 of 80), respectively (P <0.0001). The CFTR gene mutations were all Ile556Val. A multivariate analysis of HTG patients indicated that triglycerides, CFTR 470Val, and TNF promoter 863A were independent risk markers for HLP.
Conclusions: This genetic study is the first one to address the association of HLP with the CFTR mutation/variant/haplotype and TNF promoter polymorphism in a Chinese HTG population. The results suggest that the occurrence of HLP is multifactorial and polygenic.
Similar articles
-
Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.Am J Gastroenterol. 2008 Feb;103(2):368-74. doi: 10.1111/j.1572-0241.2007.01695.x. Epub 2007 Dec 12. Am J Gastroenterol. 2008. PMID: 18076731
-
Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.Pancreas. 2006 Oct;33(3):221-7. doi: 10.1097/01.mpa.0000232014.94974.75. Pancreas. 2006. PMID: 17003641
-
Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis.Clin Genet. 2007 May;71(5):451-7. doi: 10.1111/j.1399-0004.2007.00788.x. Clin Genet. 2007. PMID: 17489851
-
Genetic background of pancreatitis.Postgrad Med J. 2006 Dec;82(974):775-8. doi: 10.1136/pgmj.2006.050591. Postgrad Med J. 2006. PMID: 17148697 Free PMC article. Review.
-
Role of genetic disorders in acute recurrent pancreatitis.World J Gastroenterol. 2008 Feb 21;14(7):1011-5. doi: 10.3748/wjg.14.1011. World J Gastroenterol. 2008. PMID: 18286680 Free PMC article. Review.
Cited by
-
Predicting Severity in Hypertriglyceridemia-Induced Acute Pancreatitis: The Role of Neutrophils, Calcium, and Apolipoproteins.Med Sci Monit. 2024 Feb 7;30:e942832. doi: 10.12659/MSM.942832. Med Sci Monit. 2024. PMID: 38321725 Free PMC article.
-
Insulin Monotherapy for Hypertriglyceridemic Pancreatitis in Non-diabetic Patients: A Case Report and Literature Review.Cureus. 2025 Apr 27;17(4):e83057. doi: 10.7759/cureus.83057. eCollection 2025 Apr. Cureus. 2025. PMID: 40432658 Free PMC article.
-
TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome (MODS) in acute pancreatitis.Pancreatology. 2012 Mar-Apr;12(2):113-8. doi: 10.1016/j.pan.2012.02.014. Epub 2012 Feb 25. Pancreatology. 2012. PMID: 22487520 Free PMC article.
-
Cystic Fibrosis and Hemochromatosis Carriers May Be Prone to Glucagon-like Peptide-1 Agonist Pancreatitis: 3 Cases.JCEM Case Rep. 2025 May 15;3(7):luaf104. doi: 10.1210/jcemcr/luaf104. eCollection 2025 Jul. JCEM Case Rep. 2025. PMID: 40384889 Free PMC article.
-
Plasmapheresis as an Alternative Treatment of Hypertriglyceridemia-Induced Pancreatitis: A Case Report.Cureus. 2022 Nov 29;14(11):e32000. doi: 10.7759/cureus.32000. eCollection 2022 Nov. Cureus. 2022. PMID: 36589169 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous